Company Filing History:
Years Active: 2025
Title: Inventor Anne Urfer-Buchwalder: Pioneering Alzheimer's Disease Research
Introduction
Anne Urfer-Buchwalder, based in Belmont, California, is an innovative inventor recognized for her significant contributions to the field of Alzheimer's disease research. With a patent that addresses crucial diagnostic and therapeutic approaches, she stands at the forefront of advancements that aim to combat this debilitating condition.
Latest Patents
Urfer-Buchwalder holds a patent titled "Use of APOE4 motif-mediated genes for diagnosis and treatment of Alzheimer's disease." This groundbreaking invention outlines compositions and methods utilizing APOE4 motif-mediated genes and their expression products. The focus is on diagnosing, treating, and preventing Alzheimer's disease and mild cognitive impairment. Additionally, the patent presents methodologies for identifying therapeutic agents to aid in the diagnosis and treatment of these conditions, showcasing Urfer-Buchwalder’s commitment to improving health outcomes for affected individuals.
Career Highlights
Throughout her career, Urfer-Buchwalder has made significant strides in the realm of biomedical research, with her work leading to impactful insights into neurodegenerative diseases. Her affiliation with Selonterra, Inc. further emphasizes her dedication to integrating scientific research with practical applications, facilitating advancements in healthcare.
Collaborations
One of her notable collaborators is Roman Urfer, who works alongside her at Selonterra, Inc. Their partnership exemplifies the collaborative spirit in research and innovation, highlighting the importance of teamwork in addressing complex health challenges.
Conclusion
Anne Urfer-Buchwalder is a testament to the power of innovation in the medical field. Through her patent focused on Alzheimer's disease, she contributes significantly to the ongoing efforts to understand and treat cognitive impairments. Her work at Selonterra, Inc. positions her as a key figure in the fight against Alzheimer's, and her collaboration with dedicated colleagues enhances the potential for breakthroughs that could change lives.